Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Location of Intravitreal Bevacizumab Injection
NCT02790775Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2015
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bevacizumab in diabetic macular edema (DME), age-related macular degeneration (AMD), proliferative diabetic retinopathy (PDR) and 1 more (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Pain Score on Visual Analog Scale. Started Dec 2015; status: completed.
02
Drugs
bevacizumab
03
Conditions
diabetic macular edema (DME)age-related macular degeneration (AMD)proliferative diabetic retinopathy (PDR)cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT02790775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790775.